Our Partners
Regenerative Medicine
Our Regenerative Medicine Division specialises in a range of efficacious products that support healing and rejuvenation across many areas of wellness and healthy ageing.
Through collaboration with global partners, we strive to bring pioneering advancements in the restoration, repair, and rejuvenation of damaged cells to Australia. Our innovative technologies aim to revolutionise treatments to support the enhancement of health and vitality in patients. Our portfolio boasts plant-based exosomes to assist skin regeneration and hair restoration, Platelet-Rich Plasma (PRP) supporting skin rejuvenation, hair restoration, and the tissue and joint healing process, and varicose and spider vein treatment solutions.
Aesthetic Management Partners
A leading manufacturer of transformative aesthetic treatments, Aesthetic Management Partners boasts several restoration, repair, and rejuvenation solutions. At InterMed, we proudly represent EXO|E for skin regeneration and DE|RIVE for hair restoration, plant-based exosome products developed to support cell-to-cell messaging, accelerated healing, inflammation reduction, and collagen, hyaluronic acid, and elastin production. Adding EXO|E and DE|RIVE to aesthetic treatments assists in reducing downtime and maximises results.
Estar Medical
Globally recognised as the leading provider of a patented platform method to produce Autologous Platelet Rich Plasma (PRP), we proudly represent the Estar Tropocells® and Cellenis® products. Utilising a patient’s own blood derived plasma, PRP supports growth factors and healing properties for skin rejuvenation, hair restoration, and tissue and joint healing. This cutting-edge technology has indications in multiple disciplines including dermatology, aesthetics, orthopaedics, sports medicine, wound care, pain management, dental, ophthalmology, veterinary and more.
STD Pharmaceuticals
In collaboration with Kreussler Pharma, STD Pharmaceuticals produce, market, and distribute Fibrovein, a detergent based sclerosant licensed for the treatment of varicose veins. Occluding veins by the process of sclerosis, the aim is to promote the production of maximum endothelial damage with subsequent minimal thrombus formation aiding fibrosis of the treated vein.